Home > IVD Products > ImmunoAssays > Auto-Immunity > TRAb human 1 Step RIA > TRAb human 1 Step, RIA, 100 tests

TRAb human 1 Step, RIA, 100 tests

The TRAb human 1 Step RIA is used for the quantitative determination of Thyrotropin (TSH) receptor autoantibodies in human serum for the diagnostics of autoimmune diseases of thyroid gland. The majority of TSH receptor autoantibodies (TRAb) mimic the action of TSH on thyroid cells and thus increase blood levels of T4 and T3. Due to absence of a negative feedback system, the stimulation of the thyroid gland often leads to the clinical thyrotoxic state of Graves’ disease. Consequently, the measurement of TRAb is valuable for the differential diagnosis of hyperthyroidism as well as for the followup of Graves' disease, both during and after its treatment by antithyroid drugs, radioiodine therapy or surgery. Pregnant women developing Graves' disease can transfer their autoantibodies to the fetus via the placental unit. The higher the TRAb concentrations of the mother, the greater the risk for the embryo to develop Graves' disease in uterus and thus to suffer from congenital hyperthyroidism.

Catalog # KIPM2042
Format RIA
Label I125
Size 100 tests
Sample Type Serum
Sample Volume 100 µL
Controls 2 levels
Range 1 - 50 IU/l
Sensitivity 0,17 IU/l
Incubation 2h at RT with shaking
Shelf Life (weeks) 6.5

Due to local registration requirement, this product can not be sold in Canada, United States, Australia – without prior registration.

For Japan and Brazil, specific registration requirements are necessary. For more information, please contact: regulatory.affairs@diasource.be.

Documents - Download
Download "Instructions for Use" KIPM2042.pdf
Download catalogue "RIA" CATRv2201.pdf
Download RIA Availability Calendar
Bridging Science And Diagnostics
Choose my country

DIAsource ImmunoAssays (formerly BioSource), experienced diagnostic manufacturer of RIA-ELISA-LIA immunoassays, validation on automates, large scale production of Antibodies-Point of Care Tests.

Please select your country to see the most accurate content available in your area.